Notice: This company has been marked as potentially delisted and may not be actively trading. Can B (CANB) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesTrends CANB vs. MEDS, BIMI, MCK, COR, CAH, HLF, NUS, COSM, HWH, and TRAWShould you be buying Can B stock or one of its competitors? The main competitors of Can B include TRxADE HEALTH (MEDS), BIMI (BIMI), McKesson (MCK), Cencora (COR), Cardinal Health (CAH), Herbalife (HLF), Nu Skin Enterprises (NUS), Cosmos Health (COSM), HWH International (HWH), and Traws Pharma (TRAW). Can B vs. TRxADE HEALTH BIMI McKesson Cencora Cardinal Health Herbalife Nu Skin Enterprises Cosmos Health HWH International Traws Pharma TRxADE HEALTH (NASDAQ:MEDS) and Can B (NASDAQ:CANB) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, community ranking, earnings, risk, analyst recommendations, valuation, institutional ownership, profitability and media sentiment. Does the media refer more to MEDS or CANB? In the previous week, TRxADE HEALTH's average media sentiment score of 0.00 beat Can B's score of -0.14 indicating that TRxADE HEALTH is being referred to more favorably in the media. Company Overall Sentiment TRxADE HEALTH Neutral Can B Neutral Do insiders and institutionals believe in MEDS or CANB? 5.7% of TRxADE HEALTH shares are held by institutional investors. Comparatively, 6.1% of Can B shares are held by institutional investors. 48.4% of TRxADE HEALTH shares are held by insiders. Comparatively, 11.4% of Can B shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable earnings and valuation, MEDS or CANB? Can B has lower revenue, but higher earnings than TRxADE HEALTH. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTRxADE HEALTH$7.45M1.43-$17.84MN/AN/ACan B$2.16M1.12-$9.74MN/AN/A Which has more risk & volatility, MEDS or CANB? TRxADE HEALTH has a beta of 2.32, indicating that its share price is 132% more volatile than the S&P 500. Comparatively, Can B has a beta of 1.32, indicating that its share price is 32% more volatile than the S&P 500. Does the MarketBeat Community believe in MEDS or CANB? TRxADE HEALTH received 4 more outperform votes than Can B when rated by MarketBeat users. However, 58.62% of users gave Can B an outperform vote while only 52.50% of users gave TRxADE HEALTH an outperform vote. CompanyUnderperformOutperformTRxADE HEALTHOutperform Votes2152.50% Underperform Votes1947.50% Can BOutperform Votes1758.62% Underperform Votes1241.38% Is MEDS or CANB more profitable? TRxADE HEALTH has a net margin of -149.81% compared to Can B's net margin of -1,238.33%. Can B's return on equity of 0.00% beat TRxADE HEALTH's return on equity.Company Net Margins Return on Equity Return on Assets TRxADE HEALTH-149.81% -196.79% -112.21% Can B -1,238.33%N/A -218.65% SummaryTRxADE HEALTH beats Can B on 8 of the 12 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get Can B News Delivered to You Automatically Sign up to receive the latest news and ratings for CANB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CANB vs. The Competition Export to ExcelMetricCan BDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.42M$19.76B$5.14B$9.08BDividend YieldN/A1.47%5.09%4.23%P/E RatioN/A10.7690.0517.18Price / Sales1.128.901,117.14116.99Price / CashN/A12.2743.0437.86Price / Book-0.1113.334.784.78Net Income-$9.74M$862.89M$120.31M$225.60M Can B Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CANBCan BN/A$0.03-4.6%N/A-4.4%$2.42M$2.16M0.0016Gap UpMEDSTRxADE HEALTHN/A$7.47-4.5%N/A+54.9%$10.50M$7.45M0.0050Gap DownBIMIBIMIN/A$0.01flatN/A-99.7%$87,000.00$12.63M0.00520MCKMcKesson4.9579 of 5 stars$573.67-0.4%$643.43+12.2%+30.0%$72.82B$330.19B29.8451,000Analyst ForecastCORCencora4.7197 of 5 stars$231.05-0.5%$275.60+19.3%+14.0%$44.66B$638.56M30.9246,000CAHCardinal Health4.7227 of 5 stars$117.17-0.8%$126.75+8.2%+19.3%$28.36B$224.45B22.9848,900Analyst ForecastHLFHerbalife4.6857 of 5 stars$7.23-3.3%$9.90+36.9%-56.6%$728.73M$5.00B8.669,200NUSNu Skin Enterprises3.6498 of 5 stars$7.34-2.0%$8.88+20.9%-65.8%$364.88M$1.78B-3.593,700Analyst ForecastAnalyst RevisionGap DownCOSMCosmos Health0.3522 of 5 stars$0.70-2.5%N/A-54.5%$16.38M$53.38M-0.29123Gap UpHWHHWH InternationalN/A$0.56-16.6%N/AN/A$15.06MN/A0.00N/ANews CoverageGap UpTRAWTraws PharmaN/A$4.89+5.2%N/AN/A$14.82M$230,000.000.0017Gap Down Related Companies and Tools Related Companies MEDS Competitors BIMI Competitors MCK Competitors COR Competitors CAH Competitors HLF Competitors NUS Competitors COSM Competitors HWH Competitors TRAW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CANB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Can B Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Can B With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CANB Stock Alerts